Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds
Cafepharma Message Boards
by cafead
1h ago
via Roche released its first-quarter 2024 earnings results on Wednesday posting a 6% decline in sales compared to the same prior year period, as the company continued to be weighed down by weak demand for COVID-19 products and currency headwinds while narrowly beating analysts’ expectations. article source ..read more
Visit website
Biogen cost cuts drive profit beat, Alzheimer's drug sales jump
Cafepharma Message Boards
by cafead
1h ago
via Biogen (BIIB.O) beat market estimates for first-quarter profit on Wednesday as a series of cost-cutting measures helped offset the impact of fierce competition for its older drugs, sending its shares up nearly 7% before the bell. article source ..read more
Visit website
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Cafepharma Message Boards
by cafead
1h ago
via About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk's (NOVOb.CO) weight-loss drug Wegovy, a study published by Kaiser Family Foundation (KFF) showed on Wednesday. article source ..read more
Visit website
BSX will be larger than MDT by June
Cafepharma Message Boards
by anonymous
1h ago
BSX will dethrone MDT by June. Thanks GM snd Board... How will we spin this one ..read more
Visit website
Account Executive - Hospice
Cafepharma Message Boards
by CP Staff
1h ago
Account Executive - Hospice click for more ..read more
Visit website
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
Cafepharma Message Boards
by cafead
2h ago
via Day One Biopharmaceuticals on Tuesday announced that it has secured the FDA’s accelerated approval for tovorafenib, which will be marketed under the brand name Ojemda, for the treatment of relapsed or refractory pediatric low-grade glioma in patients aged six months and older. article source ..read more
Visit website
A
by
ago
A ..read more
Visit website
A
by
ago
A ..read more
Visit website
A
by
ago
A ..read more
Visit website
A
by
ago
A ..read more
Visit website

Follow Cafepharma Message Boards on FeedSpot

Continue with Google
Continue with Apple
OR